OCRHIPAA Privacy Rule

HIPAA Privacy Rule: General Rules for Uses and Disclosures (45 CFR 164.502)

The general rules covered entities follow for any use or disclosure of protected health information, including the minimum necessary standard and treatment, payment, and operations exceptions.

Primary source

45 CFR 164.502 — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.502

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.502 sets the baseline rule for protected health information: a covered entity may not use or disclose PHI except as the Privacy Rule permits or requires. Permitted uses fall into a short list: to the individual, for treatment, payment, or health care operations (TPO), incident to a permitted use, pursuant to a valid authorization, or under one of the public-interest exceptions in 164.512.

The minimum necessary standard applies to most uses and disclosures: a covered entity must limit PHI to the amount reasonably needed for the purpose. Treatment disclosures to other providers are exempt from this standard, as are disclosures to the individual, disclosures required by law, and disclosures pursuant to a valid authorization.

The section also governs disclosures to business associates (requires a written contract under 164.504(e)), to personal representatives, and during practice transitions. It is the structural section of the Privacy Rule — most other Privacy Rule provisions reference 164.502 as their authorizing baseline.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.